N/A
Manufactured by Merck Sharp & Dohme LLC
73,587 FDA adverse event reports analyzed
Last updated: 2026-04-14
APREPITANT is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Merck Sharp & Dohme LLC. The most commonly reported adverse reactions for APREPITANT include NAUSEA, FATIGUE, PYREXIA, DIARRHOEA, DYSPNOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for APREPITANT.
Out of 17,742 classified reports for APREPITANT:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 73,587 FDA FAERS reports that mention APREPITANT. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include NAUSEA, FATIGUE, PYREXIA, DIARRHOEA, DYSPNOEA, VOMITING. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Merck Sharp & Dohme LLC in connection with APREPITANT. Always verify the specific product and NDC with your pharmacist.